Skip to main content
SpringerLink
Log in

Inflammatory bowel disease: drugs cost $US7 million/year in Sweden

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Inflammatory bowel disease: drugs cost $US7 million/year in Sweden. Pharmacoecon. Outcomes News 318, 8 (2001). https://doi.org/10.1007/BF03280412

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03280412

Keywords

Search

Navigation